Related Experiment Video
Updated: May 16, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Model systems for rapid and slow induction of apoptosis obtained by inducible expression of pro-apoptotic proteins
Christian Maueröder1, Ricardo A Chaurio, Stephanie Platzer
1Lehrstuhl für Mikrobiologie, Department Biologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Abstract:
Killing tumor cells is a central goal of non-surgical cancer therapy and induction of apoptosis in the malignant cells is the major strategy used to achieve it. However, this may have serious drawbacks, since apoptotic cells reportedly induce immunological tumor tolerance and activate a tumor repopulation program. The debate on which type of cell death has the most beneficial therapeutic effects in cancer treatment is intense and controversial. Stringently regulated, doxycycline-inducible transgene expression systems trigger cell death in a defined manner, which might help us find answers to these problems. A conditional suicide switch established transiently in Jurkat T-cells was used to test a set of pro-apoptotic proteins for their potency to induce cell death. The activated forms of caspase-3 (revCasp-3) and Bid (tBid) were very effective and, therefore, analyzed after stable integration into human leukemia and murine melanoma cell lines. Expression of either protein resulted in more than 95% cell death, but with strongly different kinetics. 85% cell death was observed if tBid and revCasp-3 were expressed for 4-6 hours and 18-24 hours, respectively. The human cell lines expressing these suicide switches can serve as cancer models in xeno-transplanted mice, the corresponding murine cell lines allow syngeneic and allogeneic murine cancer models to be established.
Insights
Inducing apoptosis for cancer therapy can cause immune tolerance. This study uses a doxycycline-inducible system to trigger cell death via caspase-3 or Bid, creating effective cancer models.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Cancer therapy aims to kill tumor cells, often via apoptosis, but this can paradoxically promote tumor growth and immune evasion.
- The optimal cell death strategy for cancer treatment remains debated.
- Regulated gene expression systems offer a controlled method to study cell death induction.
Purpose of the Study:
- To investigate the efficacy of pro-apoptotic proteins in inducing cancer cell death using a conditional suicide switch.
- To compare the cell death kinetics induced by activated caspase-3 and Bid.
- To establish cancer models for preclinical studies.
Main Methods:
- Developed a doxycycline-inducible transgene expression system in Jurkat T-cells.
- Tested pro-apoptotic proteins, including activated caspase-3 (revCasp-3) and truncated Bid (tBid).
- Integrated suicide switches into human leukemia and murine melanoma cell lines for stable expression.
Main Results:
- Both revCasp-3 and tBid effectively induced >95% cell death in cancer cell lines.
- tBid induced rapid cell death (85% in 4-6 hours), while revCasp-3 showed slower kinetics (85% in 18-24 hours).
- Established human and murine cell lines suitable for xenograft, syngeneic, and allogeneic cancer models.
Conclusions:
- Conditional expression of revCasp-3 and tBid represents a potent strategy for inducing cancer cell death.
- The distinct kinetics of tBid and revCasp-3 offer flexibility in therapeutic strategies.
- These engineered cell lines provide valuable preclinical models for evaluating cancer therapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Caspases
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

